Stay updated on ONO-4538 in NSCLC Clinical Trial

Sign up to get notified when there's something new on the ONO-4538 in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ONO-4538 in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change likely indicates an update in the estimated efficacy and safety of ONO-4538 in combination with carboplatin, paclitaxel, and bevacizumab compared to the placebo group in subjects with non-squamous non-small cell lung cancer.
    Difference
    0.0%
    Check dated 2024-05-07T20:43:33.000Z thumbnail image
  7. Check
    13 days ago
    Change Detected
    Summary
    The value on the webpage has been updated from 2023-12-12 to 2024-05-06, indicating a change in the study completion date for the clinical trial involving ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer. This change suggests a potential delay or extension in the study timeline, possibly affecting the availability of results or further updates.
    Difference
    1%
    Check dated 2024-05-06T19:02:46.000Z thumbnail image
  8. Check
    18 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:55:14.000Z thumbnail image

Stay in the know with updates to ONO-4538 in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ONO-4538 in NSCLC Clinical Trial page.